Cellebrite DI (CLBT) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jan, 2026Executive summary
Achieved 23% year-over-year ARR growth and 20% revenue growth in Q1 2025, with adjusted EBITDA up 34% to $23.7 million and a 22% margin, reflecting strong operating leverage and disciplined cost management.
Subscription revenue increased 21% year-over-year, now representing 89% of total revenue.
Robust performance in Americas, Latin America, and Asia-Pacific offset by softness in U.S. federal and EMEA segments; global diversification and product range supported overall results.
Continued strong adoption of Insights and Guardian solutions, with Guardian ARR growing over 100% year-over-year for the third consecutive quarter.
Strategic focus on AI, cloud agility, intelligence, and defense sectors due to rising global demand and geopolitical factors; CEO search and leadership initiatives ongoing.
Financial highlights
Q1 2025 ARR reached $408 million, up 23% year-over-year, with gross retention steady at 92%.
Q1 revenue was $107.5 million, up 20% from prior year, driven by 21% growth in subscription revenue; 89% of total revenue from subscriptions.
Non-GAAP gross margin was 84.4%, down year-over-year due to higher hosting and customer success costs.
Adjusted EBITDA was $23.7 million (22% margin), up from 19.7% in Q1 2024.
Non-GAAP net income was $26.2 million ($0.10 per diluted share), with free cash flow of $18.5 million and cash/investments totaling $509.8 million at quarter end.
Outlook and guidance
Q2 2025 ARR expected at $416–$426 million (20–23% growth); Q2 revenue guidance of $110–$116 million (15–21% growth); Q2 adjusted EBITDA expected at $26–$28 million (~24% margin).
Full-year 2025 ARR guidance maintained at $480–$495 million (21–25% growth); revenue guidance adjusted to $470–$485 million (17–21% growth); adjusted EBITDA at $113–$123 million (24–25% margin).
Full-year 2025 revenue guidance range reduced by $10 million at the low end due to timing of new business and lower one-time professional services revenue from U.S. Federal vertical.
Anticipates stronger second-half performance, especially in U.S. federal and EMEA, with majority of ARR and EBITDA typically generated in H2.
Latest events from Cellebrite DI
- AI-driven digital forensics platform accelerates growth with cloud migration and new product launches.CLBT
Morgan Stanley Technology, Media & Telecom Conference 20263 Mar 2026 - 2025 delivered 21% ARR growth, strong margins, and a robust 2026 growth outlook.CLBT
Q4 202511 Feb 2026 - Growth is fueled by digital investigation platform expansion, cloud, and AI innovation.CLBT
Bank of America Global Technology Conference 20253 Feb 2026 - Strong platform, AI innovation, and cloud growth drive solid financial outlook and market expansion.CLBT
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q2 revenue up 25%, ARR up 26%, with raised 2024 guidance and strong federal, AI momentum.CLBT
Q2 20241 Feb 2026 - Q3 2024 set records for revenue and ARR, with raised guidance and a CEO transition announced.CLBT
Q3 202416 Jan 2026 - End-to-end digital forensics platform leverages AI and cloud to drive growth and market leadership.CLBT
UBS Global Technology and AI Conference12 Jan 2026 - Q3 revenue up 18% to $126M, ARR up 19%, and Corellium deal to boost future growth.CLBT
Q3 20256 Jan 2026 - 25% ARR growth and strong margins in 2024, with 2025 guidance for continued expansion.CLBT
Q4 20246 Jan 2026